Статья

Citizen science initiative points at childhood BCG vaccination as a risk factor for COVID-19

J. de la Fuente, O. Armas, L. Sánchez-Rodríguez, C. Gortázar, A. Lukashev, C. Almazán, I. Fernández de Mera, M. Villar, M. Contreras, E. Ferreras-Colino, J. Ancāns, A. Cabezas-Cruz, J. Urra, C. Cabrera, F. Rodríguez del Río, L. Torres, A. Mihalca, F. Kabi, D. Karmacharya, E. Ramos, V. Montoro, K. Kocan, E. Blouin, H. Fragoso, S. Bermúdez, A. Estrada-Peña, L. Hernández-Triana, M. Kotsyfakis, L. Grubhoffer, G. de la Fuente, K. Deulofeu, L. Deulofeu, A. Zelinska-Fedorovych, Z. Zivkovic, A. Domingos, A. Papa, A. Nijhof, M. Florin-Christensen, L. Domínguez, M. Domínguez, J. Mosqueda, O. Merino, A. Tabor, A. Mulenga, E. Doncel-Pérez, G. Bechara, S. Ghosh, A. Torina, G. Sireci, R. Nova, J. Queirós,
2021

Current results do not provide conclusive evidence on the effect of BCG vaccination on COVID-19 alone or in combination with other factors. To address this limitation, in this study we used a citizen science initiative on the COVID-19 pandemic to collect data worldwide during 2 October 2020–30 October 2020 (1,233 individuals) in a structured way for analysing factors and characteristics of affected individuals in relation to BCG vaccination. For the first time, the results of our study suggested that vaccination with BCG may increase the risk for COVID-19 at certain age, particularly in individuals vaccinated at childhood. Childhood BCG vaccination increased the likelihood of being diagnosed with COVID-19 fivefold in COVID-19 low-incidence countries and threefold in high-incidence countries. A reasonable explanation for this effect is the activation of certain innate immunity mechanisms associated with inflammatory reactions. These factors should be considered when analysing the risks associated with this global pandemic.

Цитирование

Похожие публикации

Источник

Версии

  • 1. Version of Record от 2021-01-01

Метаданные

Об авторах
  • J. de la Fuente
    SaBio, Spain, Oklahoma State University - Stillwater
  • O. Armas
    Universidad de Castilla-La Mancha
  • L. Sánchez-Rodríguez
    Universidad de Castilla-La Mancha
  • C. Gortázar
    SaBio, Spain
  • A. Lukashev
    Sechenov First Moscow State Medical University
  • C. Almazán
  • I. Fernández de Mera
  • M. Villar
  • M. Contreras
  • E. Ferreras-Colino
  • J. Ancāns
  • A. Cabezas-Cruz
  • J. Urra
  • C. Cabrera
  • F. Rodríguez del Río
  • L. Torres
  • A. Mihalca
  • F. Kabi
  • D. Karmacharya
  • E. Ramos
  • V. Montoro
  • K. Kocan
  • E. Blouin
  • H. Fragoso
  • S. Bermúdez
  • A. Estrada-Peña
  • L. Hernández-Triana
  • M. Kotsyfakis
  • L. Grubhoffer
  • G. de la Fuente
  • K. Deulofeu
  • L. Deulofeu
  • A. Zelinska-Fedorovych
  • Z. Zivkovic
  • A. Domingos
  • A. Papa
  • A. Nijhof
  • M. Florin-Christensen
  • L. Domínguez
  • M. Domínguez
  • J. Mosqueda
  • O. Merino
  • A. Tabor
  • A. Mulenga
  • E. Doncel-Pérez
  • G. Bechara
  • S. Ghosh
  • A. Torina
  • G. Sireci
  • R. Nova
  • J. Queirós
Название журнала
  • Transboundary and Emerging Diseases
Номер гранта
  • undefined
Тип документа
  • journal article
Тип лицензии Creative Commons
  • CC BY
Правовой статус документа
  • Свободная лицензия
Источник
  • scopus